Table 3.
Patient outcomes. Comparison between patients with ARDS who demonstrated influenza A(H1N1) infection (ARDSH1N1) and who did not (ARDSother)
| ARDSH1N1 (n = 49) | ARDSother (n = 11) | |
|---|---|---|
| Survival at ICU discharge | 35 (71) | 6 (54) |
| Survival at hospital discharge | 35 (71) | 6 (54) |
| Tracheostomy | 23 (49) | 6 (55) |
| Infection | 26 (53) | 4 (36) |
| CRRT | 14 (29) | 3 (27) |
| Length of ICU stay | ||
| All patients | 22 (14–37) | 17 (14–32) |
| Surviving patients | 23 (16–37) | 14 (12–32) |
| Length of hospital stay | ||
| All patients | 39 (22–50) | 40 (32–47) |
| Surviving patients | 43 (28–54) | 42 (34–54) |
| Days of MV | ||
| All patients | 18 (14–41) | 21 (13–31) |
| Surviving patients | 19 (15–37) | 18.5 (11–27.5) |
| Days of ECMO | ||
| All patients | 10 (7–17) | 8 (3–21) |
| Surviving patients | 9 (7–15) | 8 (2–15) |
| Cause of death | ||
| MOF due to sepsis | 8 (57.2) | 2 (40) |
| Neurological disorder | 1 (7.2) | 1 (20) |
| Acute liver failure | 1 (7.2) | – |
| Right heart failure | 1 (7.2) | – |
| Septic shock | 3 (21.2) | 2 (40) |
| ECMO-related complications, n (n ECMO complication-related deaths) | ||
| CNS hemorrhage | 1 (1) | – |
| Abdominal bleeding | 2 (0) | – |
| Airways bleeding | 1 (0) | – |
| Cannulation complications | 4 (0) | – |
Data presented as n (%) for categorical variables and median (interquartile range) for parametric variables
CRRT Continuous renal replacement therapy, ICU intensive care unit, MV mechanical ventilation, MOF multiple organ failure, CNS central nervous system
* P < 0.05 ARDSH1N1 versus ARDSother